Share
3,241 Posts.
lightbulb Created with Sketch. 606
clock Created with Sketch. 18/01/19
12:21
Share
Originally posted by Myownmoney
↑
I believe the current share price is still too high. Starpharma developments have been extremely delayed and the Astrazenica programs appear to have hit a sustained stop posture. Azd0466 appears to be going nowhere. Our price rose From well below $1 as the vivagel saga diminished however now it is likely back front and centre. I think 80c share price is realistic before the possibility of the fda totally rejecting vivagel approval. I believe starpharma is too frail for management to come clean and cease dep docetaxel phase 2 if it’s going wrong. We may watch it progress slowly as the sign of trouble. It should be rocketing along with 4 sites recruiting.
Expand
Such a gloomy outlook! I don't understand why you still hold if you feel this way. No point waiting for 80c when you can get $1.15 today? Its still a massive long term buy for me even if the short term outlook is volatile.
